In vivo microdialysis studies of age-related alterations in potassium-evoked overflow of dopamine in the dorsal striatum of Fischer 344 rats

International Journal of Developmental Neuroscience

Volumn 18, Issue 4-5, 2000, Pages 411-416

  Stanford, John A ^a,b   Giardina, Karen ^a   Gerhardt, Greg A ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b Morris K Udall Parkinson's Disease Research Center of Excellence   (United States)

Author keywords

Aging; Dopamine; Microdialysis; Potassium; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; POTASSIUM;

AGING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; AGING; ANIMALS; BRAIN CHEMISTRY; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; MALE; MICRODIALYSIS; POTASSIUM; RATS; RATS, INBRED F344;

EID: 0034237399     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(00)00009-5     Document Type: Article

References (34)

1. Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., Goetz C.G., Pilgrim D.M., Evans D.A. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N. Eng. J. Med. 334:1996;71-76.
2. Carlsson A., Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in the human basal ganglia. J. Neural Transm. 38:1976;271-276.
3. de Koning-Verest I.F., Knook D.L., Wolthius O.L. Behavioral and biochemical correlates of aging in rats. Stein D.G. The Psychobiology of Aging: Problems and Perspectives. 1980;177-199 Elsevier, Amsterdam.
4. Dluzen D.E., McDermott J.L., Ramirez V.D. Changes in dopamine release in vitro from the corpus striatum of young vs aged rats as a function of infusion modes of L-DOPA, potassium, and amphetamine. Exp. Neurol. 112:1991;153-160.
5. Emborg M.E., Ma S.Y., Mufson E.J., Levey A.I., Taylor M.D., Brown W.D., Holden J.E., Kordower J.H. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J. Comp. Neurol. 401:1998;253-265.
6. Emerich D.F., McDermott P., Krueger P., Banks M., Zhao J., Marszalkowski J., Frydel B., Winn S.R., Sanberg P.R. Locomotion of aged rats: relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons. Brain Res. Bull. 32:1993;477-486.
7. Finch C.E. Catecholamine metabolism in the brains of ageing male mice. Brain Res. 52:1973;261-276.
8. Friedemann M.N. In vivo electrochemical studies of dopamine diffusion and clearance in the striatum of young and aged Fischer-344 rats. Age. 15:1992;23-28.
9. Friedemann M.N., Gerhardt G.A. Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol. Aging. 13:1992;325-332.
10. Gerhardt G.A., Cass W.A., Henson M., Zhang Z., Ovadia A., Hoffer B.J., Gash D.M. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the Rhesus monkey. Neurobiol. Aging. 16:(6):1995;939-946.
11. Gerhardt G.A., Maloney R.E. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats. Brain Res. 816:(1):1999;68-77.
12. Giorgi O., Calderini G., Toffano G., Biggio G. D-1 dopamine receptors labelled with 3-H-SCH-23390: decrease in the striatum of aged rats. Neurobiol. Aging. 8:(1):1987;51-54.
13. Gregerson K.A., Selmanoff M. Changes in the kinetics of [3H] dopamine release from median eminence and striatal synaptosomes during aging. Endocrinology. 126:1990;228-234.
14. Hebert M.A., Gerhardt G.A. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats. Brain Res. 797:1998;42-54.
15. Hebert M.A., Gerhardt G.A. Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study. J. Pharmacol. Exp. Ther. 288:(2):1999;879-887.
16. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45:1987;19-34.
17. Ingram D.K., Joseph J.A., Spangler E.L., Roberts D., Hengemihle J., Fanelli R.J. Chronic nimodipine treatment in aged rats: analysis of motor and cognitive effects and muscarinic-induced striatal dopamine release. Neurobiol. Aging. 15:1994;55-61.
18. Irwin I., DeLanney L.E., McNeill T., Chan P., Forno L.S., Murphy G.M. Jr, Di Monte D.A., Sandy M.S., Langston J.W. Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration. 3:(4):1994;251-265.
19. Kametani H., Iijima S., Spangler E.L., Ingram D.K., Joseph J.A. In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat. Neurobiol. Aging. 16:1995;639-646.
20. Lai H., Bowden D.M., Horita A. Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the Rhesus monkey (Macaca mulatta). Neurobiol. Aging. 8:1987;45-49.
21. Leenders K.L., Salmon E.P., Tyrrell P., Perani D., Brooks D.J., Sager H., Jones T., Marsden C.D., Frackowiak S.J. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch. Neurol. 47:1990;1290-1298.
22. McGeer P.L., McGeer E.G., Suzuki J.S. Aging and extrapyramidal function. Arch. Neurol. 34:1977;33-35.
23. Mortimer J.A., Webster D.D. Comparison of extrapyramidal motor function in normal aging and parkinson's disease. Mortimer J.A., Pirozzolo F.J., Maletta G.J. Advances in Neurology: Vol. 3. The aging motor system. 1982;217-241 Praeger Scientific, New York.
24. Nakano M., Mizuno T. Age-related changes in the metabolism of neurotransmitters in rat striatum: a microdialysis study. Mech. Ageing Dev. 86:1996;95-104.
25. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates: Compact. 3rd ed. 1997;Academic Press, San Diego.
26. Ponzio F., Brunello N., Algeri S. Catecholamine synthesis in brain of aging rat. J. Neurochem. 30:1978;1617-1620.
27. Santiago M., Machado A., Cano J. Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study. Mech. Ageing Dev. 67:1993;261-267.
28. Severson J.A., Randall P.K. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites. J. Pharmacol. Exp. Ther. 233:(2):1985;361-368.
29. Strong R., Samorajski T., Gottesfeld Z. Regional mapping of neostriatal neurotransmitter systems as a function of aging. J. Neurochem. 39:1982;831-836.
30. Teräväinen H., Calne D.B. Motor system in normal aging and Parkinson's disease. Katzman R., Terry R. The Neurology of Aging. 1983;85-109 Davis, Philadelphia.
31. Yurek D.M., Hipkins S.B., Hebert M.A., Gash D.M., Gerhardt G.A. Age-related decline in striatal dopamine release and motoric function in Brown Norway/Fischer 344 hybrid rats. Brain Res. 791:1998;246-256.
32. Zelnik N., Angel I., Paul S.M., Kleinman J.E. Decreased density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126:1986;175-176.
33. Zigmond M.J., Acheson A.L., Stachowiak M.K., Stricker E.M. Neurochemical compensation after nigrostriatal injury in an animal model of preclinical parkinsonism. Arch Neurol. 41:1984;856-861.
34. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 12:1990;290-296.